These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33725777)

  • 1. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
    Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
    Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.
    Huang W; Zhang Q; Wu G; Chen PP; Li J; McCabe Gillen K; Spincemaille P; Chiang GC; Gupta A; Wang Y; Chen F
    Radiother Oncol; 2021 Nov; 164():146-154. PubMed ID: 34592360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of quantitative parameters of magnetic resonance perfusion-weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia-inducible factor-1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study.
    Hu Y; E H; Yu X; Li F; Zeng L; Lu Q; Xi X; Shen L
    Clin Otolaryngol; 2018 Apr; 43(2):425-433. PubMed ID: 28892580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasopharyngeal carcinoma perfusion MRI: Comparison of arterial spin labeling and dynamic contrast-enhanced MRI.
    Xiao B; Wang P; Zhao Y; Liu Y; Ye Z
    Medicine (Baltimore); 2020 May; 99(22):e20503. PubMed ID: 32481470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
    Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
    BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravoxel Incoherent Motion Combined With Dynamic Contrast-Enhanced Perfusion MRI of Early Cervical Carcinoma: Correlations Between Multimodal Parameters and HIF-1α Expression.
    Li X; Wu S; Li D; Yu T; Zhu H; Song Y; Meng L; Fan H; Xie L
    J Magn Reson Imaging; 2019 Sep; 50(3):918-929. PubMed ID: 30648775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCE-MRI in Human Gliomas: A Surrogate for Assessment of Invasive Hypoxia Marker HIF-1Α Based on MRI-Neuronavigation Stereotactic Biopsies.
    Xie Q; Wu J; Du Z; Di N; Yan R; Pang H; Jin T; Zhang H; Wu Y; Zhang Y; Yao Z; Feng X
    Acad Radiol; 2019 Feb; 26(2):179-187. PubMed ID: 29754996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
    Sriyook A; Lertbutsayanukul C; Jittapiromsak N
    Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.
    Song C; Cheng P; Cheng J; Zhang Y; Sun M; Xie S; Zhang X
    Eur Radiol; 2020 Jan; 30(1):110-118. PubMed ID: 31372786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between parameters of dynamic contrast-enhanced MRI and clinical stage of nasopharyngeal carcinoma].
    Yu X; Li F; Hu Y; Lu Q; Wang H
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):597-602. PubMed ID: 26714600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
    Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
    J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing mesorectal tumor deposits from metastatic lymph nodes by using diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
    Xu Q; Xu Y; Wang J; Sun H; Lin J; Xie S
    Eur Radiol; 2023 Jun; 33(6):4127-4137. PubMed ID: 36520180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.
    Zheng D; Chen Y; Chen Y; Xu L; Chen W; Yao Y; Du Z; Deng X; Chan Q
    J Magn Reson Imaging; 2014 Apr; 39(4):940-8. PubMed ID: 24108569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.
    Huang B; Wong CS; Whitcher B; Kwong DL; Lai V; Chan Q; Khong PL
    Eur Radiol; 2013 Jun; 23(6):1495-502. PubMed ID: 23377545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience of correlating parameters of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging at 3.0 T in nasopharyngeal carcinoma.
    Jia QJ; Zhang SX; Chen WB; Liang L; Zhou ZG; Qiu QH; Liu ZY; Zeng QX; Liang CH
    Eur Radiol; 2014 Dec; 24(12):3076-87. PubMed ID: 25052079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.
    Lindgren A; Anttila M; Rautiainen S; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
    PLoS One; 2019; 14(8):e0221340. PubMed ID: 31437208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-tumor histogram analysis of diffusion-weighted imaging and dynamic contrast-enhanced MRI for soft tissue sarcoma: correlation with HIF-1alpha expression.
    Li X; Hu Y; Xie Y; Lu R; Li Q; Tao H; Chen S
    Eur Radiol; 2023 Jun; 33(6):3961-3973. PubMed ID: 36462043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Tumor Hypoxia in C6 Glioma Rat Model With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Hou W; Xue Y; Tang W; Pan H; Xu M; Li X; Bi S; Shen Y; Qian Y; Yu Y
    Acad Radiol; 2019 Aug; 26(8):e224-e232. PubMed ID: 30385206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced magnetic resonance imaging in cervical cancer: correlation between quantitative parameters and molecular markers hypoxia-inducible factors-1-alpha, vascular endothelial growth factor, and Ki-67.
    Liu B; Gao H; Zhou F; Zhao W; Yang Y
    Clin Radiol; 2024 Jun; 79(6):e826-e833. PubMed ID: 38582634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic utility of combining dynamic contrast-enhanced magnetic resonance imaging with arterial spin labeling in the staging of nasopharyngeal carcinoma.
    Li H; Gong G; Wang L; Su Y; Lu J; Yin Y
    BMC Med Imaging; 2023 May; 23(1):61. PubMed ID: 37138205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.